Agios Pharmaceuticals Closes Initial Public Offering, Underwriters Exercised Full Option

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ) today announced the closing of its initial public offering of 6,772,221 shares of its common stock at a public offering price of $18.00 per share, before underwriting discounts, including 883,333 shares of common stock issued upon the exercise in full by the underwriters